blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3515549

EP3515549 - DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION AND AGENT FOR USE WITH SUCH DEVICE [Right-click to bookmark this link]
Former [2019/31]METHOD AND DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION
[2023/01]
StatusThe patent has been granted
Status updated on  20.10.2023
Database last updated on 16.07.2024
FormerGrant of patent is intended
Status updated on  08.06.2023
FormerExamination is in progress
Status updated on  15.05.2023
FormerGrant of patent is intended
Status updated on  04.01.2023
FormerExamination is in progress
Status updated on  11.02.2022
FormerRequest for examination was made
Status updated on  28.06.2019
FormerThe international publication has been made
Status updated on  30.03.2018
Most recent event   Tooltip12.07.2024Lapse of the patent in a contracting state
New state(s): DK, SM		published on 14.08.2024 [2024/33]
Applicant(s)For all designated states
Inovio Pharmaceuticals, Inc.
660 W. Germantown Pike
Suite 110
Plymouth Meeting, PA 19462 / US
[2019/31]
Inventor(s)01 / FISHER, Paul
c/o Inovio Pharmaceuticals, Inc.
660 W. Germantown Pike, Suite 110
Plymouth Meeting, PA 19462 / US
02 / BRODERICK, Kate
c/o Inovio Pharmaceuticals, Inc.
660 W. Germantown Pike, Suite 110
Plymouth Meeting, PA 19462 / US
03 / MCCOY, Jay
c/o Inovio Pharmaceuticals, Inc.
660 W. Germantown Pike, Suite 110
Plymouth Meeting, PA 19462 / US
 [2019/31]
Representative(s)Leonard, Thomas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2019/31]
Application number, filing date17853993.822.09.2017
[2019/31]
WO2017US52970
Priority number, dateUS201662398932P23.09.2016         Original published format: US 201662398932 P
US201762480180P31.03.2017         Original published format: US 201762480180 P
[2019/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018057900
Date:29.03.2018
Language:EN
[2018/13]
Type: A1 Application with search report 
No.:EP3515549
Date:31.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 29.03.2018 takes the place of the publication of the European patent application.
[2019/31]
Type: B1 Patent specification 
No.:EP3515549
Date:22.11.2023
Language:EN
[2023/47]
Search report(s)International search report - published on:US29.03.2018
(Supplementary) European search report - dispatched on:EP12.05.2020
ClassificationIPC:A61N1/32, A61N1/04
[2020/24]
CPC:
A61N1/0412 (EP,CN,KR); A61N1/327 (EP,CN,KR,US); A61M37/00 (CN,KR);
A61N1/0416 (CN,US); A61N1/042 (KR); A61N1/0424 (KR);
A61N1/325 (CN); A61M2037/0007 (CN,KR); A61N1/0404 (US) (-)
Former IPC [2019/31]A61N1/18, A61N1/32
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/31]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VORRICHTUNG FÜR MINIMAL-INVASIVE IN-VIVO-TRANSFEKTION VON FETTGEWEBE MITTELS ELEKTROPORATION UND MITTEL ZUR VERWENDUNG MIT DIESER VORRICHTUNG[2023/01]
English:DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION AND AGENT FOR USE WITH SUCH DEVICE[2023/01]
French:DISPOSITIF DE TRANSFECTION IN VIVO MINIMALEMENT INVASIVE DE TISSU ADIPEUX À L'AIDE D'ÉLECTROPORATION ET AGENT À UTILISER AVEC CE DISPOSITIF[2023/01]
Former [2019/31]VERFAHREN UND VORRICHTUNG FÜR MINIMAL-INVASIVE IN-VIVO-TRANSFEKTION VON FETTGEWEBE MITTELS ELEKTROPORATION
Former [2019/31]METHOD AND DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION
Former [2019/31]PROCÉDÉ ET DISPOSITIF DE TRANSFECTION IN VIVO MINIMALEMENT INVASIVE DE TISSU ADIPEUX À L'AIDE D'ÉLECTROPORATION
Entry into regional phase29.03.2019National basic fee paid 
29.03.2019Search fee paid 
29.03.2019Designation fee(s) paid 
29.03.2019Examination fee paid 
Examination procedure29.03.2019Examination requested  [2019/31]
14.12.2020Amendment by applicant (claims and/or description)
15.02.2022Despatch of a communication from the examining division (Time limit: M06)
25.08.2022Reply to a communication from the examining division
05.01.2023Communication of intention to grant the patent
12.05.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
09.06.2023Communication of intention to grant the patent
12.10.2023Fee for grant paid
12.10.2023Fee for publishing/printing paid
12.10.2023Receipt of the translation of the claim(s)
Divisional application(s)EP23187369.6  / EP4238607
Fees paidRenewal fee
27.09.2019Renewal fee patent year 03
28.09.2020Renewal fee patent year 04
15.09.2021Renewal fee patent year 05
11.08.2022Renewal fee patent year 06
24.08.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.11.2023
DK22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
[2024/33]
Former [2024/26]AT22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/25]AT22.11.2023
HR22.11.2023
LT22.11.2023
PL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/24]AT22.11.2023
HR22.11.2023
LT22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/23]AT22.11.2023
LT22.11.2023
BG22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/21]LT22.11.2023
BG22.02.2024
GR23.02.2024
IS22.03.2024
Former [2024/20]GR23.02.2024
IS22.03.2024
Documents cited:Search[XI]US2003149451  (CHOMENKY VICTOR I [US], et al);
 [X]US2005182462  (CHORNENKY VICTOR I [US], et al);
 [X]US2007060989  (DEEM MARK E [US], et al);
 [X]US2011009860  (CHORNENKY VICTOR I [US], et al);
 [X]US2011190659  (LONG GARY L [US], et al);
 [X]WO2015192018  (IOWA APPROACH INC [US])
International search[X]US2003149451  (CHOMENKY VICTOR I [US], et al);
 [X]US2005182462  (CHORNENKY VICTOR I [US], et al);
 [A]US2006293725  (RUBINSKY BORIS [US], et al);
 [A]US2011112520  (MICHAEL KREINDEL [CA]);
 [Y]US2011190659  (LONG GARY L [US], et al);
 [XY]US2014277219  (NANDA GURVINDER SINGH [US])
ExaminationWO2009091578
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.